Navigation Links
'Cash For Crow's Feet' Program Offers Effective - and Affordable - Laser Skin Treatments
Date:9/9/2009

ATLANTA, Sept 9 /PRNewswire/ -- The government's "Cash for Clunkers" program may have ended, but financial incentives for improving health and appearance are still available.

Georgia's DeKalb Surgical Associates' "Cash for Crow's Feet" program offers a top-of-the-line skin rejuvenation and repair procedure - fractional laser treatment - at half the typical cost, said Dr. David R. Fern, FACS. Dr. Fern and the Vein & Skin Laser Center are affiliated with DeKalb Surgical Associates, a multi-specialty practice in the Atlanta area that serves patients throughout the southeast. "Our 'whole-face at half-off' philosophy is in response to all the factors at play in the current economic environment," said Dr. Fern. "Patients who may have lost their jobs or are 'reinventing' themselves in new positions or as entrepreneurs starting new businesses need to look their best. And some are using this opportunity to treat long-standing skin and vein problems that need medically correcting."

The American Society of Plastic Surgeons reported recently that professional women, in particular, see procedures such as skin rejuvenation treatments as "employment insurance" to stay or become competitive in their careers. Total cosmetic procedures and minimally-invasive cosmetic procedures have increased since 2007 (3% and 5%, respectively), while more involved surgical cosmetic procedures are down 9% overall. (See http://www.prnewswire.com/mnr/aacs/36867/) "Staying youthful-looking is still a priority for people," said Dr. Fern, "especially when the treatment options are effective - and affordable."

One of the more popular skin rejuvenation treatments available today is the minimally-invasive fractional laser treatment ActiveFX, which uses the latest-generation Lumenis laser. The procedure is used to treat scars, age spots, melasma ("mask of pregnancy"), and wrinkles. A high-energy laser beam interacts with the skin's surface, causing the upper layer to peel off and regenerate a layer of new, healthy skin. The "fractional" pattern leaves small bridges of untouched skin, resulting in a much quicker healing process. "For most patients, ActiveFX can be done on the entire face with one treatment lasting less than an hour," said Dr. Fern.

Fractional laser treatments range from $2,000 to $6,000 nationwide. DeKalb Surgical Associates' "Cash for Crow's Feet" incentive offers the ActiveFX treatment for $1,750, compared to its normal cost of $3,500.

Dr. Fern and the Center also offer several types of non-surgical treatments for vein problems, including the VNUS Closure radio-frequency procedure (as seen on "Good Morning America" on September 3, 2009), laser therapy, and injection schlerotherapy. Dr. Fern is a Fellow of the American College of Surgeons and was in the charter class for Board certification in phlebology, which has only 248 diplomates nationwide. He has been involved in the treatment of skin diseases, skin cancer, melanoma, and vein surgery for 30 years.

The Center offers a free initial consultation with Dr. Fern and certified aesthetician Jigna Naik. For more information, call 404-508-4320.


'/>"/>
SOURCE DeKalb Surgical Associates
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Hard to Treat Diseases, Inc. (HTDS) and Landstar Inc (LDSR) Cash Reward
2. MedQuist Announces Establishment of Revolving Credit Facility and Payment of Special Cash Dividend
3. Endo Pharmaceuticals Announces Cash Tender Offer for Any and All Outstanding Ledgemont PhaRMA(SM) Secured 16% Notes
4. Perrigo Reports Record Sales, Earnings and Cash Flow From Operations for Fiscal 2009
5. CA$H-First(SM) LTCi Provides First-Day Cash Benefits at Affordable Rates
6. Service Corporation International Declares Quarterly Cash Dividend
7. Quest Diagnostics Declares Quarterly Cash Dividend
8. Unilens Vision Inc. Declares Regular Quarterly Cash Dividend of U.S. $0.09 Per Share
9. STAAR Surgical Generates Cash From Operations During Second Quarter
10. Duane Reade Holdings, Inc. Amends Terms and Extends Deadlines for Previously Announced Cash Tender Offers for Senior Secured Floating Rate Notes and Senior Subordinated Notes
11. Webmedx Appoints New Senior Vice President of Client Development, Chris Cashwell
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2016)... ... 05, 2016 , ... The University of Western States (UWS) ... 2016 National SACA Leadership Conference on the Portland campus September 23-25. The conference ... come together and develop skills to be future leaders in the profession. ...
(Date:5/5/2016)... ... May 05, 2016 , ... ... has found that more than 40 percent of participating fifth-grade students already have ... of Allergy and Asthma Clinical Research in the Division of Pulmonary, Allergy and ...
(Date:5/5/2016)... ... 2016 , ... In order to increase comfort, convenience and ... Seattle-based steam bath and sauna manufacturer recently launched amerecConnect™ , a new ... app, developed for both smartphones and personal computers perfectly emulates that of the ...
(Date:5/5/2016)... ... 2016 , ... United Collection Bureau, Inc. (UCB) announces Sarah Clark as its ... of experience within the healthcare revenue cycle industry. With a primary focus of end-to-end ... Financial Services at Spectrum Health. While at Spectrum Health, Clark helped Spectrum achieve the ...
(Date:5/5/2016)... ... May 05, 2016 , ... CURE Media Group ... today announced a new collaboration with Imerman Angels to expand outreach and ... the world. , “Imerman Angels provides an emotional lifeline to patients and families facing ...
Breaking Medicine News(10 mins):
(Date:5/4/2016)... Conn., May 4, 2016  Compass Diversified Holdings (NYSE: ... "Company"), an owner of leading middle market businesses, announced ... ended March 31, 2016. First Quarter 2016 ... and Reinvestment ("CAD" or "Cash Flow") of $13.6 million ... net loss of $15.0 million for the first quarter ...
(Date:5/4/2016)... May 4, 2016 Yissum ... announced today that it had signed an exclusive ... , developer of novel protein degradation and immunomodulatory drugs ... commercialization of drug candidates representing first-in-class therapy for hematologic ... not disclosed. The novel technology was developed ...
(Date:5/4/2016)... 4, 2016 Research ... "Global Acute Myeloid Leukemia Market and Competitive ... offering.       (Logo: http://photos.prnewswire.com/prnh/20160330/349511LOGO ... Market and Competitive Landscape Highlights 2016, provides ... products, Acute Myeloid Leukemia epidemiology, Acute Myeloid ...
Breaking Medicine Technology: